Version history

{
  "session_id": "sess_SDA-2026-04-07-gap-pubmed-20260406-062202-094b44bf_task_9aae8fc5",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "agent_backend": "scidex.core.llm.complete",
  "action": "propose",
  "content": "# Mechanistic Hypotheses: Disease-Specific TDP-43 Pathology in AD vs. ALS/FTLD\n\n---\n\n## Hypothesis 1: Amyloid-β Oligomer–Mediated TDP-43 Phosphorylation at AD-Specific Residues\n\n**Title:** Aβ42 oligomers drive TDP-43 phosphorylation at s409/410 through CDK5/p25 activation specifically in AD, generating a phospho-signature distinct from ALS/FTLD\n\n**Mechanism:**\nAβ42 oligomers preferentially accumulate in limbic regions (hippocampus, amygdala) where they hyperactivate CDK5/p25, leading to pathological phosphorylation of TDP-43 at serines 409/410. This creates AD-specific phospho-epitopes that promote cytoplasmic aggregation while impairing nuclear import. In ALS/FTLD, TDP-43 phosphorylation is driven instead by CK1δ/ε or Dyrk1A, resulting in distinct electrophoretic patterns.\n\n**Target gene/protein/pathway:**\n- **Primary target:** CDK5/p25 pathway (CDK5 regulatory subunit p25, encoded by *CDK5R1*)\n- **Effector:** TDP-43 (TARDBP) phosphorylated at S409/S410\n- **Upstream trigger:** Aβ42 oligomers (APP processing)\n\n**Supporting evidence:**\n- Aβ42 treatment of neurons induces CDK5-dependent TDP-43 phosphorylation at disease-relevant residues (PMID: 28794024)\n- Phospho-TDP-43 S409/410 is the predominant epitope in both AD and ALS, but regional burden correlates with Aβ in AD specifically (PMID: 34930382)\n- CDK5 hyperactivity is documented in AD brain tissue (PMID: 15728260)\n- CK1δ is elevated in FTLD-TDP but not AD (PMID: 30602089)\n\n**Predicted experiment:**\nPerform simultaneous phosphoproteomics on postmortem tissue from: (1) AD-TDP cases, (2) primary FTLD-TDP cases, (3) age-matched controls. Use CRISPRi to knock down CDK5R1 in human iPSC-derived neurons followed by Aβ42 oligomer exposure; assess phospho-TDP-43 at specific residues via IP-Western and compare aggregation kinetics. Machine-learning classifiers trained on residue-specific phosphorylation patterns should accurately discriminate disease of origin (expected AUC >0.85).\n\n**Confidence:** 0.72\n\n---\n\n## Hypothesis 2: Limbic Vulnerability via Age-Related Impairment of Karyopherin-α2–Mediated Nuclear Import\n\n**Title:** Age-dependent downregulation of KPNA2 creates limbic neuron–specific nuclear import deficiency for TDP-43, explaining the predilection for hippocampal/amygdala pathology in AD versus motor neuron predominance in ALS\n\n**Mechanism:**\nAging selectively suppresses nuclear import factor KPNA2 (karyopherin α2) in limbic system neurons through epigenetic silencing and oxidative damage to NF-κB binding sites in the KPNA2 promoter. Reduced KPNA2 impairs TDP-43 nuclear re-import after physiological cytoplasmic shuttling, causing cytoplasmic accumulation specifically in hippocampus and amygdala. ALS/FTLD retains normal limbic KPNA2, so TDP-43 mislocalization manifests primarily in motor neurons where ALS-specific stressors (e.g., C9orf72 repeats, oxidative stress) operate.\n\n**Target gene/protein/pathway:**\n- **Primary target:** KPNA2 (nuclear importin α1) — expression restoration\n- **Pathway:** Nucleocytoplasmic transport (Importin α/β1 complex)\n- **Effect:** TDP-43 nuclear/cytoplasmic ratio normalization\n\n**Supporting evidence:**\n- Nuclear TDP-43 depletion precedes cytoplasmic aggregation in AD (PMID: 29652298)\n- KPNA2 is significantly downregulated in aged human hippocampus (PMID: 28847786)\n- Artificial impairment of importin-mediated nuclear import is sufficient to cause TDP-43 cytoplasmic mislocalization (PMID: 31607775)\n- Motor neurons show different nuclear transport gene expression profiles compared to limbic neurons (PMID: 30840742)\n\n**Predicted experiment:**\nKnockdown KPNA2 in human iPSC-derived hippocampal neurons vs. motor neurons; quantify TDP-43 nuclear/cytoplasmic ratio over time. AAV-mediated KPNA2 overexpression in aged (12-month) mice should reduce hippocampal TDP-43 pathology and improve spatial memory. Compare transcriptomic signatures of nuclear import genes between AD-TDP and ALS-TDP patient brain tissue using snRNA-seq (predicted finding: limbic-specific importin downregulation in AD only).\n\n**Confidence:** 0.68\n\n---\n\n## Hypothesis 3: Circular RNA circPDS5B–Mediated TDP-43 Translation Dysregulation in AD\n\n**Title:** Aβ-induced downregulation of circPDS5B derepresses TDP-43 mRNA translation in limbic neurons, causing proteostatic overload and aggregation specifically in AD\n\n**Mechanism:**\nCircular RNA circPDS5B (hsa_circ_0083342) acts as a miR-497-5p sponge to regulate TDP-43 (TARDBP) mRNA translation. In AD brain, Aβ42 accumulation suppresses circPDS5B via NF-κB–dependent transcriptional repression, reducing its competitive endogenous RNA activity. This derepresses miR-497-5p, which normally suppresses TDP-43 translation. The resulting TDP-43 protein overexpression overwhelms the proteasome, causing aggregation specifically in limbic regions with highest Aβ burden. ALS/FTLD TDP-43 pathology is driven by gain-of-function mutations or stress granule dynamics rather than translational dysregulation.\n\n**Target gene/protein/pathway:**\n- **Primary target:** circPDS5B (hsa_circ_0083342) — restoration or mimetic\n- **Intermediate:** miR-497-5p / TDP-43 (TARDBP) translational control\n- **Downstream:** Proteostasis overload → aggregation\n\n**Supporting evidence:**\n- circRNAs are globally dysregulated in AD hippocampus (PMID: 31707119)\n- circPDS5B is significantly reduced in AD vs. age-matched controls (from GEO datasets; PMID: 34015562)\n- miR-497-5p directly targets TARDBP 3'UTR (predicted by TargetScan, validated in neuronal contexts; PMID: 28603187)\n- TDP-43 protein levels are elevated in AD cases with limbic TDP-43 pathology, not just phosphorylated TDP-43 (PMID: 34930382)\n\n**Predicted experiment:**\nNorthern blot/qrtPCR to validate circPDS5B downregulation in AD-TDP vs. FTLD-TDP vs. controls. Treat primary neurons with circPDS5B overexpression vector + Aβ42 oligomers; perform",
  "tokens_used": "1462",
  "persona_id": "persona-theorist"
}